Tremfya (Guselkumab)
Tremfya (Guselkumab)
Tremfya (guselkumab) is a prescription medication used for the treatment of moderate to severe plaque psoriasis in adults who may benefit from systemic therapy or phototherapy, and adult patients with active psoriatic arthritis. As a selective IL-23 inhibitor, Tremfya targets specific proteins that are associated with inflammatory processes of the disease, helping to reduce symptoms and manage the conditions effectively.Why Choose Tremfya (Guselkumab)?
- Targeted Treatment: Tremfya specifically targets the IL-23 protein, a key driver of inflammatory processes in psoriasis, providing focused and effective treatment.
- Improves Skin Clearance: Clinically proven to help achieve clearer skin in many patients with plaque psoriasis.
- Long-lasting Effects: Offers sustained symptom control with appropriate usage, which can improve the quality of life.
- Convenient Dosing: Administered as an injection once every 8 weeks after initial starter doses, allowing for less frequent dosing compared to some other therapies.
How to Use Tremfya (Guselkumab)?
- Initial Dosing: Tremfya is administered as a subcutaneous injection. The recommended initial dose is given at week 0, followed by a second dose at week 4.
- Maintenance Dosing: After the initial doses, Tremfya is typically given once every 8 weeks.
- Administration: Always use Tremfya exactly as your healthcare provider has instructed. The injection can be done at home by the patient or a caregiver, following training by a healthcare professional.
- Storage and Handling: Store in a refrigerator, protect from light, and do not freeze. Allow the medication to reach room temperature before injecting.
Important Safety Information about Tremfya
- Infections: Tremfya may increase the risk of infections. Tell your doctor if you have signs of an infection, such as fever, sweats, or chills.
- Allergic Reactions: If you experience any symptoms of a serious allergic reaction such as hives, difficulty breathing, or swelling of your face, lips, tongue, or throat, seek medical attention immediately.
- Vaccinations: Avoid using live vaccines while taking Tremfya. Discuss your vaccination history with your healthcare provider.
Fact Table
| Facts | Details |
| Generic Name | Guselkumab |
| Brand Name | Tremfya |
| FDA Approval | Approved in 2017 for plaque psoriasis; later approved for psoriatic arthritis. |
| Drug Type | Monoclonal antibody |
| Mechanism of Action | Inhibits the interleukin-23 (IL-23) protein which is involved in inflammation. |
| Indications | Moderate to severe plaque psoriasis, active psoriatic arthritis in adults. |
| Administration | Subcutaneous injection |
| Dosage Form | Pre-filled syringe |
| Initial Dosing | 100 mg at week 0, followed by 100 mg at week 4 |
| Maintenance Dosing | 100 mg every 8 weeks |
| Common Side Effects | Upper respiratory infections, headaches, injection site reactions, joint pain, diarrhea, fungal skin infections |
| Special Considerations | Screen for TB before treatment; monitor for signs of infection; avoid live vaccines during treatment |
| Storage Requirements | Store in refrigerator, protect from light, do not freeze |
Common Side Effects
Like all medications, Tremfya (Guselkumab) can cause side effects, although not everybody gets them. Understanding these side effects can help you use this medication safely and effectively.- Upper respiratory infections
- Headaches
- Injection site reactions
- Joint pain
- Diarrhea
How Can You Buy Tremfya (Guselkumab)?
You can order Tremfya (Guselkumab) using these methods on our website:- Order Online
- Order by Phone
- Order by Fax
- Order your refills
